Clinical Trials Logo

Clinical Trial Summary

The study aims to evaluate the bone architecture and bone strength in adults with Hypophosphatasia (HPP).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04181164
Study type Observational
Source Hvidovre University Hospital
Contact
Status Active, not recruiting
Phase
Start date October 1, 2019
Completion date December 30, 2021

See also
  Status Clinical Trial Phase
Completed NCT00952484 - Safety and Efficacy of Asfotase Alfa in Juvenile Patients With Hypophosphatasia (HPP) Phase 2
Completed NCT00744042 - Safety and Efficacy Study of Asfotase Alfa in Severely Affected Infants With Hypophosphatasia (HPP) Phase 1/Phase 2
Completed NCT02104219 - Retrospective, Non-interventional Natural History of Patients With Juvenile-onset Hypophosphatasia (HPP)
Completed NCT01419028 - A Retrospective Study of the Natural History of Patients With Severe Perinatal and Infantile Hypophosphatasia (HPP)
Completed NCT00739505 - Safety Study of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP) Phase 1
Completed NCT01203826 - Extension Study of Protocol ENB-006-09 - Study of Asfotase Alfa in Children With Hypophosphatasia (HPP) Phase 2
Enrolling by invitation NCT02306720 - Registry of Patients With Hypophosphatasia